Oncology Models | Charles River Discovery Services

Oncology Models 

Charles River Discovery Services offers validated human tumor xenografts, primary tumor, syngeneic, drug resistant, and specialty models in support of your drug development program. Through our broad range of service offerings and scientific expertise, our discovery team works with you to choose the most appropriate study design and screening method for an investigational agent. Depending on client needs, tumor growth delay (TGD), tumor growth inhibition (TGI), survival, combination or adjuvant design approaches may be used.  Studies can be designed to:

  • Identify leads
  • Optimize dose schedules
  • Identify optimal combination strategies
  • Evaluate drug resistance/sensitivity patterns

 

Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
mai 14 - New Models for Evaluating COPD or ...
mai 11 - Expert Safety Testing to Accelerat...
juin 17-juin 20 -  Noordwijk aan Zee, the Netherlands - 19th MDO Meeting / 12th Europea...
juin 02-juin 05 - Vancouver, British Columbia - CALAS
juin 05-juin 05 - King of Prussia, Pennsylvania - Assessment of Immunomodulation for Bi...
juin 05-juin 08 - Saint Germain sur l’Arbresle, France - Charles River LAL Seminar Seri...
view all
RMS Specialist Montreal, Canada

Charles River Laboratories, Inc.